{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:15Z","timestamp":1792787955540,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ80462"],"award-info":[{"award-number":["2025JJ80462"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research of Hunan Provincial Health Commission","award":["D202304056751"],"award-info":[{"award-number":["D202304056751"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002715"],"award-info":[{"award-number":["82002715"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20190170"],"award-info":[{"award-number":["BK20190170"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of the Scientific Research of Hunan Provincial Health Commission","award":["D202214023516"],"award-info":[{"award-number":["D202214023516"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04175-5","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:39:10Z","timestamp":1768207150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-omics analysis identifies BUB1B as a cell cycle\u2013related driver of bladder cancer progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Huidong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaodi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"4175_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Stat 2021 CA Cancer J Clin. Jan. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","DOI":"10.3322\/caac.21654"},{"key":"4175_CR2","doi-asserted-by":"publisher","unstructured":"Witjes JA et al. Mar., Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer, Eur Urol, vol. 71, no. 3, pp. 462\u2013475, 2017, https:\/\/doi.org\/10.1016\/j.eururo.2016.06.020","DOI":"10.1016\/j.eururo.2016.06.020"},{"key":"4175_CR3","doi-asserted-by":"publisher","unstructured":"Tran L, Xiao J-F, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy, Nat Rev Cancer, vol. 21, no. 2, pp. 104\u2013121, Feb. 2021, https:\/\/doi.org\/10.1038\/s41568-020-00313-1","DOI":"10.1038\/s41568-020-00313-1"},{"key":"4175_CR4","doi-asserted-by":"publisher","unstructured":"Kamran SC, Efstathiou JA. The legacy of RTOG\/NRG protocols in shaping current bladder preservation therapy in North America. Semin Radiat Oncol. Jan. 2023;33(1):26\u201334. https:\/\/doi.org\/10.1016\/j.semradonc.2022.10.004.","DOI":"10.1016\/j.semradonc.2022.10.004"},{"key":"4175_CR5","doi-asserted-by":"publisher","unstructured":"Liu J, Peng Y, Wei W. Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell Biol. Jan. 2022;32(1):30\u201344. https:\/\/doi.org\/10.1016\/j.tcb.2021.07.001.","DOI":"10.1016\/j.tcb.2021.07.001"},{"key":"4175_CR6","doi-asserted-by":"publisher","unstructured":"Bockm\u00fchl U, Petersen I. DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch. Dec. 2002;441(6):541\u201350. https:\/\/doi.org\/10.1007\/s00428-002-0729-3.","DOI":"10.1007\/s00428-002-0729-3"},{"key":"4175_CR7","doi-asserted-by":"publisher","unstructured":"Delgado L, et al. BUBR1 as a prognostic biomarker in canine oral squamous cell carcinoma. Anim (Basel). Nov. 2022;12:3082. https:\/\/doi.org\/10.3390\/ani12223082.","DOI":"10.3390\/ani12223082"},{"key":"4175_CR8","doi-asserted-by":"publisher","unstructured":"Weaver RL, Limzerwala JF, Naylor RM, Jeganathan KB, Baker DJ, van Deursen JM. BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer. Elife. Aug. 2016;5:e16620. https:\/\/doi.org\/10.7554\/eLife.16620.","DOI":"10.7554\/eLife.16620"},{"key":"4175_CR9","doi-asserted-by":"publisher","unstructured":"Scintu M et al. Sep., Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma, Cancer Lett, vol. 254, no. 2, pp. 298\u2013307, 2007, https:\/\/doi.org\/10.1016\/j.canlet.2007.03.021","DOI":"10.1016\/j.canlet.2007.03.021"},{"key":"4175_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005.","journal-title":"Comput Struct Biotechnol J"},{"key":"4175_CR11","doi-asserted-by":"publisher","unstructured":"Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for cox\u2019s proportional hazards model via coordinate descent. J Stat Softw. Mar. 2011;39(5):1\u201313. https:\/\/doi.org\/10.18637\/jss.v039.i05.","DOI":"10.18637\/jss.v039.i05"},{"key":"4175_CR12","doi-asserted-by":"publisher","unstructured":"Bustin SA, Benes V, Nolan T, Pfaffl MW. Quantitative real-time RT-PCR\u2013a perspective, J Mol Endocrinol, vol. 34, no. 3, pp. 597\u2013601, Jun. 2005, https:\/\/doi.org\/10.1677\/jme.1.01755","DOI":"10.1677\/jme.1.01755"},{"key":"4175_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-4939-2742-5_9","volume":"1318","author":"TS Hnasko","year":"2015","unstructured":"Hnasko TS, Hnasko RM. The Western blot. Methods Mol Biol. 2015;1318:87\u201396. https:\/\/doi.org\/10.1007\/978-1-4939-2742-5_9.","journal-title":"Methods Mol Biol"},{"key":"4175_CR14","doi-asserted-by":"publisher","unstructured":"Nizio\u0142 M, Zi\u0144czuk J, Zar\u0119ba K, Guzi\u0144ska-Ustymowicz K, Pryczynicz A. Immunohistochemical analysis of the expression of adhesion proteins: TNS1, TNS2 and TNS3 in correlation with clinicopathological parameters in gastric cancer. Biomolecules. Apr. 2021;11(5):640. https:\/\/doi.org\/10.3390\/biom11050640.","DOI":"10.3390\/biom11050640"},{"key":"4175_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.pathol.4.110807.092230","volume":"4","author":"AP Mitra","year":"2009","unstructured":"Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009;4:251\u201385. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092230.","journal-title":"Annu Rev Pathol"},{"key":"4175_CR16","doi-asserted-by":"publisher","unstructured":"Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification, J Clin Oncol, vol. 24, no. 35, pp. 5552\u20135564, Dec. 2006, https:\/\/doi.org\/10.1200\/JCO.2006.08.2073","DOI":"10.1200\/JCO.2006.08.2073"},{"key":"4175_CR17","doi-asserted-by":"publisher","unstructured":"Prinz F, et al. Functional and structural characterization of Bub3\u00b7BubR1 interactions required for spindle assembly checkpoint signaling in human cells. J Biol Chem. May 2016;291:11252\u201367. https:\/\/doi.org\/10.1074\/jbc.M115.702142.","DOI":"10.1074\/jbc.M115.702142"},{"key":"4175_CR18","doi-asserted-by":"publisher","unstructured":"Simonetti G, Bruno S, Padella A, Tenti E, Martinelli G. Aneuploidy: Cancer strength or vulnerability? Int J Cancer, vol. 144, no. 1, pp. 8\u201325, Jan. 2019, https:\/\/doi.org\/10.1002\/ijc.31718","DOI":"10.1002\/ijc.31718"},{"key":"4175_CR19","doi-asserted-by":"publisher","unstructured":"Elowe S. Bub1 and BubR1: at the interface between chromosome attachment and the spindle checkpoint. Mol Cell Biol. Aug. 2011;31(15):3085\u201393. https:\/\/doi.org\/10.1128\/MCB.05326-11.","DOI":"10.1128\/MCB.05326-11"},{"key":"4175_CR20","doi-asserted-by":"publisher","unstructured":"Hanks S et al. Nov., Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B, Nat Genet, vol. 36, no. 11, pp. 1159\u20131161, 2004, https:\/\/doi.org\/10.1038\/ng1449","DOI":"10.1038\/ng1449"},{"key":"4175_CR21","doi-asserted-by":"publisher","unstructured":"Koyuncu D, Sharma U, Goka ET, Lippman ME. Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival. Breast Cancer Res Treat. Jan. 2021;185(2):331\u201341. https:\/\/doi.org\/10.1007\/s10549-020-05962-2.","DOI":"10.1007\/s10549-020-05962-2"},{"issue":"9","key":"4175_CR22","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2174\/1871520620666200101141934","volume":"20","author":"J-H Tian","year":"2020","unstructured":"Tian J-H, et al. BUB1B promotes proliferation of prostate cancer via transcriptional regulation of MELK. Anticancer Agents Med Chem. 2020;20(9):1140\u20136. https:\/\/doi.org\/10.2174\/1871520620666200101141934.","journal-title":"Anticancer Agents Med Chem"},{"key":"4175_CR23","doi-asserted-by":"publisher","unstructured":"Ma Q, Liu Y, Shang L, Yu J, Qu Q. The FOXM1\/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma, Oncol Rep, vol. 38, no. 6, pp. 3367\u20133375, Dec. 2017, https:\/\/doi.org\/10.3892\/or.2017.6032","DOI":"10.3892\/or.2017.6032"},{"key":"4175_CR24","doi-asserted-by":"publisher","unstructured":"Kops GJPL, Foltz DR, Cleveland DW. Lethality to human cancer cells through massive chromosome loss by Inhibition of the mitotic checkpoint. Proc Natl Acad Sci U S A. Jun. 2004;101(23):8699\u2013704. https:\/\/doi.org\/10.1073\/pnas.0401142101.","DOI":"10.1073\/pnas.0401142101"},{"key":"4175_CR25","doi-asserted-by":"publisher","unstructured":"Lei X, et al. CD4\u2009+\u2009helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nat Commun. Jan. 2023;14(1):217. https:\/\/doi.org\/10.1038\/s41467-022-35615-5.","DOI":"10.1038\/s41467-022-35615-5"},{"key":"4175_CR26","doi-asserted-by":"publisher","unstructured":"Basile G et al. Dec., Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial, Clin Cancer Res, vol. 28, no. 23, pp. 5107\u20135114, 2022, https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2158","DOI":"10.1158\/1078-0432.CCR-22-2158"},{"key":"4175_CR27","doi-asserted-by":"publisher","unstructured":"Li X, Wang W, Ding X. Pan-cancer investigation of psoriasis-related BUB1B gene: genetical alteration and oncogenic immunology. Sci Rep. Apr. 2023;13(1):6058. https:\/\/doi.org\/10.1038\/s41598-023-33174-3.","DOI":"10.1038\/s41598-023-33174-3"},{"key":"4175_CR28","doi-asserted-by":"publisher","unstructured":"Liu X, et al. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis. J Exp Clin Cancer Res. Dec. 2022;41(1):353. https:\/\/doi.org\/10.1186\/s13046-022-02558-0.","DOI":"10.1186\/s13046-022-02558-0"},{"key":"4175_CR29","doi-asserted-by":"publisher","unstructured":"Helt CE, Cliby WA, Keng PC, Bambara RA, O\u2019Reilly MA. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage, J Biol Chem, vol. 280, no. 2, pp. 1186\u20131192, Jan. 2005, https:\/\/doi.org\/10.1074\/jbc.M410873200","DOI":"10.1074\/jbc.M410873200"},{"key":"4175_CR30","doi-asserted-by":"publisher","unstructured":"Honaker Y, Piwnica-Worms H. Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction, Oncogene, vol. 29, no. 23, pp. 3324\u20133334, Jun. 2010, https:\/\/doi.org\/10.1038\/onc.2010.96","DOI":"10.1038\/onc.2010.96"},{"key":"4175_CR31","doi-asserted-by":"publisher","unstructured":"Liu Z, et al. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and Endoplasmic reticulum stress. J Exp Clin Cancer Res. Jul. 2020;39(1):144. https:\/\/doi.org\/10.1186\/s13046-020-01646-3.","DOI":"10.1186\/s13046-020-01646-3"},{"key":"4175_CR32","doi-asserted-by":"publisher","unstructured":"Guo Q et al. Mar., NF-\u03baB in biology and targeted therapy: new insights and translational implications, Signal Transduct Target Ther, vol. 9, no. 1, p. 53, 2024, https:\/\/doi.org\/10.1038\/s41392-024-01757-9","DOI":"10.1038\/s41392-024-01757-9"},{"key":"4175_CR33","doi-asserted-by":"publisher","unstructured":"Huang F et al. Jul., RBM7 deficiency promotes breast cancer metastasis by coordinating MFGE8 splicing switch and NF-kB pathway, Elife, vol. 13, p. RP95318, 2024, https:\/\/doi.org\/10.7554\/eLife.95318","DOI":"10.7554\/eLife.95318"},{"key":"4175_CR34","doi-asserted-by":"publisher","unstructured":"Jiang N, et al. BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway. J Exp Clin Cancer Res. Dec. 2021;40(1):378. https:\/\/doi.org\/10.1186\/s13046-021-02179-z.","DOI":"10.1186\/s13046-021-02179-z"},{"key":"4175_CR35","doi-asserted-by":"publisher","unstructured":"Ishteyaque S, et al. Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma. Metabolism. Mar. 2024;152:155771. https:\/\/doi.org\/10.1016\/j.metabol.2023.155771.","DOI":"10.1016\/j.metabol.2023.155771"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04175-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:25:35Z","timestamp":1770643535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04175-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4175"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04175-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7503441\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Institutional Review Committee of the Affiliated Changsha Hospital of Hunan Normal University (ethical approval codes:CSSDSYY-LLSC-KYXM-2022-8-19). Written informed consent was achieved from each adult participant. Research has been carried out according to the ARRIVE guidelines, where applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}